For the risk stratification of indeterminate thyroid nodules

Please visit us at ENDOExpo 2024 (Booth 626)

microRNA Profiling Augments Mutation Status in the Risk Stratification of Thyroid Nodules with a Suspicious for Malignancy (Bethesda-V) Cytology Diagnosis

ATA Annual Meeting, 2024
  • To assess the utility of microRNA (miRNA) profiling in augmenting oncogene testing in thyroid nodule aspirates with a
    Suspicious for Malignancy (Bethesda V) cytology diagnosis

Patient management decisions are based on the independent medical judgment of the physician and molecular test results should be taken into consideration in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference.